Area of research
Hepatology · Epidemiology
Research interest
Research interests include Liver Disease and Transplantation, Liver Disease Diagnosis and Treatment, Gut microbiota and health, and Organ Transplantation Techniques and Outcomes.
An observational study on the effect of l-ornithine-l-aspartate (LOLA) on the gut microbiome in liver cirrhosis. A single center phase 4 study
The beneficial effect of a multispecies probiotic intervention on quality of sleep - a randomized, double-blinded, placebo-controlled study.
Prognostic Value of Exercise Testing in Patients with Liver Cirrhosis.
Microbial Dysbiosis in the Urinary Microbiome of Patients With Cirrhosis.
Response-guided bulevirtide ± pegylated interferon alfa-2a: long-term outcomes observed in the nationwide Austrian hepatitis D cohort study.
MyBioScope: a new frontier in gut microbiome and health research
Surgery and the Gastrointestinal Microbiome in Cancer: Bidirectional Impacts and Therapeutic Opportunities – a Narrative Review
The microplastic-crisis: Role of bacteria in fighting microplastic-effects in the digestive system.
Depletion of Small HDL Subclasses Predicts Poor Survival in Liver Cirrhosis.
Human gut microbiome: Therapeutic opportunities for metabolic syndrome-Hype or hope?
Alteration of the Gut-Lung Axis After Severe COVID-19 Infection and Modulation Through Probiotics: A Randomized, Controlled Pilot Study.
Probiotic Therapy of Gastrointestinal Symptoms During COVID-19 Infection: A Randomized, Double-Blind, Placebo-Controlled, Remote Study.
Gut Microbiome Changes After Neoadjuvant Chemotherapy and Surgery in Patients with Gastric Cancer.
Cellular and Microbial In Vitro Modelling of Gastrointestinal Cancer.
Effect of albumin infusion on oxidative albumin modification and albumin binding capacity in chronic liver failure.
Altered gut microbiome, bile acid composition and metabolome in sarcopenia in liver cirrhosis.
Fungal translocation measured by serum 1,3-ß-D-glucan correlates with severity and outcome of liver cirrhosis-A pilot study.
Circulating neutrophil anti-pathogen dysfunction in cirrhosis.
Probiotic OMNi-BiOTiC<sup>®</sup> 10 AAD Reduces Cyclophosphamide-Induced Inflammation and Adipose Tissue Wasting in Mice.
Liver-Gut-Interaction: Role of Microbiome Transplantation in the Future Treatment of Metabolic Disease.
Transplantation of hepatitis D virus patients: Lifelong hepatitis B immunoglobulins?
Serum bile acids in liver cirrhosis promote neutrophil dysfunction.
Changing paradigms in the treatment of gastrointestinal complications of cystic fibrosis in the era of cystic fibrosis transmembrane conductance regulator modulators.
A novel score predicts mortality after transjugular intrahepatic portosystemic shunt: MOTS - Modified TIPS Score.
Insights into the Composition of a Co-Culture of 10 Probiotic Strains (OMNi BiOTiC<sup>®</sup> AAD10) and Effects of Its Postbiotic Culture Supernatant.
Pulmonary vascular disease and exercise hemodynamics in chronic liver disease.
Oral Intake of L-Ornithine-L-Aspartate Is Associated with Distinct Microbiome and Metabolome Changes in Cirrhosis.
Red urine and a red herring - diagnosing rare diseases in the light of the COVID-19 pandemic.
The Pre-Analytical CEN/TS Standard for Microbiome Diagnostics-How Can Research and Development Benefit?
Criminal and Civil Responsibility of the Donor in a Case of Transmission of Malaria by a Blood Transfusion in a Nonendemic Country.